As of January 22, 2025, Metagenomi (MGX) has a market cap of $0.11 billion USD. According to our data, Metagenomi is ranked No.7594 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.11 B |
-16.07%
|
Dec 31, 2024 | $0.14 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Pacific Biosciences
PACB
|
$0.53 B |
-0.000 M
|
USA
|
10x Genomics
TXG
|
$1.97 B |
0.229 B
|
USA
|
Bionano Genomics
BNGO
|
$25.94 M |
0.000 M
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
Twist Bioscience
TWST
|
$3.12 B |
0.000 M
|
USA
|
Personalis
PSNL
|
$0.47 B |
0.000 M
|
USA
|
Fulgent Genetics
FLGT
|
$0.52 B |
-0.000 M
|
USA
|
Market Cap | = | MGX Stock Price | * | MGX Shares Outstanding |
= | $3.03 | * | 37.42 M | |
= | $0.11 B |